Text Size
35 studies found for:    University of Kentucky | Alzheimer's disease | United States, Kentucky

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
Interventions: Drug: alphatocopherol;   Drug: Selenium;   Drug: Placebo replacement for vitamin E;   Drug: Placebo replacement for Selenium
2 Completed Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.
Condition: Alzheimer's Disease
Intervention:
3 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
4 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab;   Drug: Placebo Control
5 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab;   Drug: Placebo Control
6 Recruiting Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Conditions: Memory Disorders;   Alzheimer Disease;   Dementia;   Cognitive Impairment;   Frontotemporal Dementia
Intervention: Device: COGNISION™ System
7 Recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease
Intervention:
8 Active, not recruiting Resveratrol for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol;   Drug: Placebo
9 Completed A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution
10 Completed Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention:
11 Completed ADNI: Alzheimer's Disease Neuroimaging Initiative
Condition: Alzheimer's Disease
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Positron Emission Tomography (PET);   Procedure: Lumbar Puncture (LP)
12 Completed Anti-Oxidant Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Vitamin E, Vitamin C, and Alpha-lipoic Acid;   Drug: Coenzyme Q;   Drug: Placebo capsules;   Drug: Placebo wafers
13 Completed A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
Condition: Alzheimer Disease
Interventions: Drug: Rofecoxib;   Drug: Naproxen
14 Not yet recruiting The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Drug: Insulin (Humulin® R U-100);   Drug: Placebo
15 Completed Agitation in Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Trazodone;   Drug: Haloperidol
16 Completed Study of Melatonin: Sleep Problems in Alzheimer's Disease
Conditions: Alzheimer Disease;   Dyssomnias
Intervention: Drug: Melatonin
17 Completed Memory Impairment Study (Mild Cognitive Impairment Study)
Condition: Alzheimer Disease
Interventions: Drug: Donepezil;   Drug: Vitamin E
18 Completed Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
Condition: Alzheimer Disease
Intervention: Drug: Simvastatin
19 Completed
Has Results 		DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: DHA (Docosahexaenoic Acid);   Drug: Placebo
20 Active, not recruiting Home-Based Assessment for Alzheimer Disease Prevention
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Behavioral: Mail and Live Phone;   Behavioral: Interactive Voice Response (IVR);   Behavioral: Home-based Computer Kiosk;   Behavioral: Traditional Evaluation Instruments
To Top

Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results
† Indicates status has not been verified in more than two years